Dr. Idan Goren, MD

Dr. Goren practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Goren's NPI, 1811691934, was assigned on March 30, 2023. Dr. Goren graduated from Odessa Medical University in 2011. Dr. Goren holds New York license 327272.

Dr. Goren's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Goren's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. The medical group on file is Department of Medicine. Dmand AI also links Dr. Goren to 2 more group practices and clinics, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goren practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Goren's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Goren's licenses on file in 2 states: New York and Ohio.

CMS data shows 141 Medicare services from Dr. Goren across 6 procedure codes in 2024, for 118 Medicare patients. Medicare paid $10,066 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw Dr. Goren in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goren's median patient age at 52, with 52% women.

In 2024, Dr. Goren wrote 29 Medicare Part D claims for 23 patients. 69% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $244 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Goren for performance year 2024, reported as part of a group. Dr. Goren accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goren as offering telehealth. CMS counts 48 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Goren, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 61 papers to Dr. Goren, published from 2014 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Crohn Disease, Colitis, Ulcerative and Inflammatory Bowel Diseases. Dr. Goren has published most often in J Crohns Colitis. Dr. Goren's most frequent co-authors are Shay Ben-Shachar, MD, Nathaniel Aviv Cohen, MD and Ayal Hirsch.

CMS Open Payments shows 1 general payment to Dr. Goren from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $29.

Dr. Goren graduated from Odessa Medical University in 2011.